Skip to main content
. 2022 Jun 5;14(6):1202. doi: 10.3390/pharmaceutics14061202

Figure 4.

Figure 4

Cellular uptake of the (A) DiI-labeled LipoIRI or (B) DiI-labeled BS−LipoIRI was examined after incubation of cells at 15 min, 30 min, 1 h, 3 h, 8 h, and 24 h. (C) BxPC3 cells were treated with DiI-labeled LipoIRI or BS−LipoIRI for 2 h in the presence of various inhibitors or without inhibitors.